Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
Arthritis Rheumatol
; 70(5): 763-773, 2018 05.
Article
in En
| MEDLINE
| ID: mdl-29381843
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sjogren's Syndrome
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents, Immunological
/
Lupus Erythematosus, Systemic
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Arthritis Rheumatol
Year:
2018
Type:
Article
Affiliation country:
France